A citation-based method for searching scientific literature

J Smith-Palmer, M Brändle, R Trevisan, M Orsini Federici, S Liabat, W Valentine. Diabetes Res Clin Pract 2014
Times Cited: 96







List of co-cited articles
411 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
27

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
679
18


Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
817
15

Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.
Catherine Gorst, Chun Shing Kwok, Saadia Aslam, Iain Buchan, Evangelos Kontopantelis, Phyo K Myint, Grant Heatlie, Yoon Loke, Martin K Rutter, Mamas A Mamas. Diabetes Care 2015
208
14

Glycemic Variability: How Do We Measure It and Why Is It Important?
Sunghwan Suh, Jae Hyeon Kim. Diabetes Metab J 2015
134
14



Glucose variability: An emerging target for the treatment of diabetes mellitus.
Simona Frontoni, Paolo Di Bartolo, Angelo Avogaro, Emanuele Bosi, Giuseppe Paolisso, Antonio Ceriello. Diabetes Res Clin Pract 2013
85
14


Glucose variability.
F John Service. Diabetes 2013
116
11

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
560
11




Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.
Yoichiro Hirakawa, Hisatomi Arima, Sophia Zoungas, Toshiharu Ninomiya, Mark Cooper, Pavel Hamet, Giuseppe Mancia, Neil Poulter, Stephen Harrap, Mark Woodward,[...]. Diabetes Care 2014
167
9


Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data.
Yongming Qu, Scott J Jacober, Qianyi Zhang, Linda L Wolka, J Hans DeVries. Diabetes Technol Ther 2012
82
9





Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups.
Nathan R Hill, Nick S Oliver, Pratik Choudhary, Jonathan C Levy, Peter Hindmarsh, David R Matthews. Diabetes Technol Ther 2011
166
8

A novel approach to continuous glucose analysis utilizing glycemic variation.
C M McDonnell, S M Donath, S I Vidmar, G A Werther, F J Cameron. Diabetes Technol Ther 2005
211
8


Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
Gong Su, Shuhua Mi, Hong Tao, Zhao Li, Hongxia Yang, Hong Zheng, Yun Zhou, Changsheng Ma. Cardiovasc Diabetol 2011
150
7

Severe hypoglycemia and risks of vascular events and death.
Sophia Zoungas, Anushka Patel, John Chalmers, Bastiaan E de Galan, Qiang Li, Laurent Billot, Mark Woodward, Toshiharu Ninomiya, Bruce Neal, Stephen MacMahon,[...]. N Engl J Med 2010
900
7


Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
7

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
7


Should minimal blood glucose variability become the gold standard of glycemic control?
Irl B Hirsch, Michael Brownlee. J Diabetes Complications 2005
281
7

The challenges of measuring glycemic variability.
David Rodbard. J Diabetes Sci Technol 2012
51
13

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
John M Lachin, Ionut Bebu, Richard M Bergenstal, Rodica Pop-Busui, F John Service, Bernard Zinman, David M Nathan. Diabetes Care 2017
78
8

Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.
Louis Monnier, Claude Colette, Anne Wojtusciszyn, Sylvie Dejager, Eric Renard, Nicolas Molinari, David R Owens. Diabetes Care 2017
120
7


Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control.
Jan Šoupal, Jan Škrha, Martin Fajmon, Eva Horová, Miloš Mráz, Jan Škrha, Martin Prázný. Diabetes Technol Ther 2014
55
10

Glucose variability; does it matter?
Sarah E Siegelaar, Frits Holleman, Joost B L Hoekstra, J Hans DeVries. Endocr Rev 2010
271
6


The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
Eric S Kilpatrick, Alan S Rigby, Stephen L Atkin. Diabetes Care 2006
228
6

THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS.
J SCHLICHTKRULL, O MUNCK, M JERSILD. Acta Med Scand 1965
374
6

Evaluation of a new measure of blood glucose variability in diabetes.
Boris P Kovatchev, Erik Otto, Daniel Cox, Linda Gonder-Frederick, William Clarke. Diabetes Care 2006
212
6

Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
M Muggeo, G Zoppini, E Bonora, E Brun, R C Bonadonna, P Moghetti, G Verlato. Diabetes Care 2000
188
6


A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
Johan Wadén, Carol Forsblom, Lena M Thorn, Daniel Gordin, Markku Saraheimo, Per-Henrik Groop. Diabetes 2009
138
6

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
6

Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction.
Gong Su, Shu-hua Mi, Hong Tao, Zhao Li, Hong-Xia Yang, Hong Zheng, Yun Zhou, Lei Tian. Diabetes Care 2013
84
7



Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
122
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.